280 related articles for article (PubMed ID: 15287365)
1. [Contrast agents in MRT. Substance, effects, pharmacology and validity].
Reimer P; Vosshenrich R
Radiologe; 2004 Mar; 44(3):273-83. PubMed ID: 15287365
[TBL] [Abstract][Full Text] [Related]
2. Safety of approved MR contrast media for intravenous injection.
Runge VM
J Magn Reson Imaging; 2000 Aug; 12(2):205-13. PubMed ID: 10931582
[TBL] [Abstract][Full Text] [Related]
3. Safety of magnetic resonance contrast media.
Runge VM
Top Magn Reson Imaging; 2001 Aug; 12(4):309-14. PubMed ID: 11687717
[TBL] [Abstract][Full Text] [Related]
4. Introduction.
Martin DR
Top Magn Reson Imaging; 2016 Dec; 25(6):255. PubMed ID: 27849655
[No Abstract] [Full Text] [Related]
5. Pathophysiology of Immediate Reactions to Injectable Gadolinium-based Contrast Agents.
Carr TF
Top Magn Reson Imaging; 2016 Dec; 25(6):265-268. PubMed ID: 27748716
[TBL] [Abstract][Full Text] [Related]
6. Allergic reactions to gadolinium chelates.
Runge VM
AJR Am J Roentgenol; 2001 Oct; 177(4):944-5. PubMed ID: 11566710
[No Abstract] [Full Text] [Related]
7. [Anaphylactoid reaction caused by intravenous gadopentetate dimeglumine in magnetic resonance].
Campos A; Aznar L; Alamar R; Castelló JV
Med Clin (Barc); 1996 Feb; 106(5):197. PubMed ID: 8684023
[No Abstract] [Full Text] [Related]
8. Updated guidelines for intravenous contrast use for CT and MRI.
Huynh K; Baghdanian AH; Baghdanian AA; Sun DS; Kolli KP; Zagoria RJ
Emerg Radiol; 2020 Apr; 27(2):115-126. PubMed ID: 31925592
[TBL] [Abstract][Full Text] [Related]
9. Preventing Allergic Reactions to Gadolinium-Based Contrast Agents.
Heshmatzadeh Behzadi A; Prince MR
Top Magn Reson Imaging; 2016 Dec; 25(6):275-279. PubMed ID: 27748715
[TBL] [Abstract][Full Text] [Related]
10. Re: chemical structure and stability of gadolinium chelates.
Idée JM; Port M; Corot C
Radiographics; 2009 Nov; 29(7):2099. PubMed ID: 19926764
[No Abstract] [Full Text] [Related]
11. Late Diagnosis of Anaphylactic Reaction to Gadolinium-Based Contrast Media by Skin Tests 10 Years After Onset.
Harr T; Jandus P
J Investig Allergol Clin Immunol; 2018 Jun; 28(3):203-205. PubMed ID: 29939144
[No Abstract] [Full Text] [Related]
12. How to Manage (Treat) Immediate-type Adverse Reactions to GBCA.
Thomsen HS
Top Magn Reson Imaging; 2016 Dec; 25(6):269-274. PubMed ID: 27849654
[TBL] [Abstract][Full Text] [Related]
13. Safety of magnetic resonance imaging contrast agents.
Shellock FG; Kanal E
J Magn Reson Imaging; 1999 Sep; 10(3):477-84. PubMed ID: 10508312
[TBL] [Abstract][Full Text] [Related]
14. Acute adverse reactions to magnetic resonance contrast media--gadolinium chelates.
Li A; Wong CS; Wong MK; Lee CM; Au Yeung MC
Br J Radiol; 2006 May; 79(941):368-71. PubMed ID: 16632615
[TBL] [Abstract][Full Text] [Related]
15. MR contrast agents, the old and the new.
Bellin MF
Eur J Radiol; 2006 Dec; 60(3):314-23. PubMed ID: 17005349
[TBL] [Abstract][Full Text] [Related]
16. Gadolinium induced anaphylaxis under general anesthesia in a patient with sickle cell disease.
Salik I; Hernandez J
J Clin Anesth; 2019 May; 54():47. PubMed ID: 30391454
[No Abstract] [Full Text] [Related]
17. MR imaging of the liver using gadolinium chelates.
Low RN
Magn Reson Imaging Clin N Am; 2001 Nov; 9(4):717-43, vi. PubMed ID: 11694435
[TBL] [Abstract][Full Text] [Related]
18. Incidence of immediate gadolinium contrast media reactions.
Prince MR; Zhang H; Zou Z; Staron RB; Brill PW
AJR Am J Roentgenol; 2011 Feb; 196(2):W138-43. PubMed ID: 21257854
[TBL] [Abstract][Full Text] [Related]
19. "Stability" of gadolinium chelates.
Tweedle MF
Br J Radiol; 2007 Jul; 80(955):583-4; author reply 584-5. PubMed ID: 17704319
[No Abstract] [Full Text] [Related]
20. Adverse reaction to intravenous gadoteridol.
Shellock FG; Hahn HP; Mink JH; Itskovich E
Radiology; 1993 Oct; 189(1):151-2. PubMed ID: 8372186
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
